Chapter 2400

Biotechnology

2401-Introduction
2402-The Deposit Rules
2403-Deposit of Biological Material
- 2403.01-Material Capable of Self- Replication
- 2403.02-Plant Material
2404-Need or Opportunity to Make a Deposit
- 2404.01-Biological Material That Is Known and Readily Available to the Public
- 2404.02-Biological Material That Can Be Made or Isolated Without Undue Experimentation
- 2404.03-Reference to a Deposit in the Specification
2405-Acceptable Depository
2406-Time of Making an Original Deposit
- 2406.01-Description in Application Specification
- 2406.02-Deposit After Filing Date - Corroboration
- 2406.03-Possible Loss of U.S. Filing Date in Other Countries
2407-Replacement or Supplement of Deposit
- 2407.01-In a Pending Application
- 2407.02-After a Patent Has Issued
- 2407.03-Failure to Replace
- 2407.04-Treatment of Replacement
- 2407.05-Exemption From Replacement
- 2407.06-Replacement May Not Be Recognized
2408-Term of Deposit
2409-Viability of Deposit
2410-Furnishing of Samples
- 2410.01-Conditions of Deposit
- 2410.02-Certification of Statement of Availability of Deposit
2411-Examination Procedures
- 2411.01-Rejections Based on Deposit Issue
- 2411.02-Replies to Rejections Based on Deposit Issue
- 2411.03-Application in Condition for Allowance Except for Deposit
- 2411.04-[Reserved]
- 2411.05-Content of Application with Respect to Deposited Material
2412‑2419-[Reserved]
2420-The Requirements for Patent Applications Containing Nucleotide Sequence and/or Amino Acid Sequence Disclosures - the Sequence Rules
2421-Overview of the Sequence Rules
- 2421.01-Definition of “Sequence Listing” and “CRF”
- 2421.02-Summary of the Requirements of the Sequence Rules
- 2421.03-Notification of a Failure to Comply
- 2421.04-Future Changes to the Sequence Rules
2422-Nucleotide and/or Amino Acid Sequence Disclosures in Patent Applications
- 2422.01-Nucleotide and/or Amino Acids Disclosures Requiring a Sequence Listing
- 2422.02-The Requirement for Exclusive Conformance; Sequences Presented in Drawing Figures
- 2422.03-Sequence Listing Submission
- 2422.03(a)-Sequence Listings Submitted as ASCII Text Files via EFS-Web
- 2422.04-The Requirement for a Computer Readable Copy of the Official Copy of the Sequence Listing
- 2422.05-Request for Transfer of Computer Readable Form
- 2422.06-Requirement for Statement Regarding Content of Official and Computer Readable Copies of Sequence Listing
- 2422.07-Requirements for Compliance, Statements Regarding New Matter, and Sanctions for Failure to Comply
- 2422.08-Presumptions Regarding Compliance
- 2422.09-Box Sequence; Hand Delivery of Sequence Listings and Computer Readable Forms
2423-Symbols and Format To Be Used for Nucleotide and/or Amino Acid Sequence Data
- 2423.01-Format and Symbols To Be Used in Sequence Listings
- 2423.02-Depiction of Coding Regions
- 2423.03-Presentation and Numbering of Sequences
2424-Requirements for Nucleotide and/or Amino Acid Sequences as Part of the Application Papers
- 2424.01-Informational Requirements for the Sequence Listing
- 2424.02-Sequence Listing Numeric Identifiers
- 2424.03-Additional Miscellaneous Requirements
2425-Form and Format for Nucleotide and/or Amino Acid Sequence Submissions in Computer Readable Form
2426-Amendments to or Replacement of Sequence Listing and Computer Readable Copy Thereof
2427-Form Paragraphs
2428-Sample Statements
2429-Helpful Hints for Compliance
2430-PatentIn Information
2431-Sample Sequence Listing
2432‑2433-[Reserved]
2434-Examination of Patent Applications Claiming Large Numbers of Nucleotide Sequences
2435-Publishing of Patents and Patent Application Publications with Lengthy Sequence Listings

This page is owned by Patents.

Last Modified: 01/24/2018 17:18:47